TD Cowen Maintains Buy on Eli Lilly (LLY) After Government Deal

Eli Lilly and Company (NYSE:LLY) is one of the 15 Best Aggressive Growth Stocks to Buy Right Now. On November 7, TD Cowen reiterated its Buy rating on Eli Lilly and Company (NYSE:LLY) with a price target of $960. This update came after the company announced an agreement with the US government to expand access to obesity medicines. Starting April 1, 2026, Medicare beneficiaries will not have to pay more than $50 per month for Zepbound (tirzepatide), which comes in a multi-dose pen, and for orforglipron, El ...